LONGEVITY & CELLULAR RESEARCH
A mitochondria-targeted tetrapeptide studied for protecting mitochondrial function and reducing oxidative stress.
SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide studied for protecting mitochondrial function, reducing oxidative stress, and supporting cellular energy. It has a specific cardiolipin-binding mechanism and has been evaluated in clinical trials for mitochondrial conditions.
Included because it has a highly specific, well-characterized mitochondrial mechanism and has been evaluated in human clinical trials for mitochondrial conditions. Its real-world use history is still developing, placing it as an emerging longevity-research compound with strong mechanistic backing.
Selectively targets and binds cardiolipin in the inner mitochondrial membrane.
Stabilizes mitochondrial structure and electron-transport-chain supercomplexes.
Enhances ATP production while reducing reactive oxygen species, without affecting healthy mitochondria.
WHAT THE RESEARCH MEASURED
Findings describe study outcomes, not expected personal results.
SS-31 (elamipretide) is investigational and not FDA-approved. Sold and offered strictly for laboratory and research use.
